Please ensure Javascript is enabled for purposes of website accessibility

Why Clover Health Stock Is Soaring Today

By Keith Speights - Jun 22, 2021 at 12:04PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company cautioned about a short squeeze, but investors seem to be shrugging off the warning.

What happened

Shares of Clover Health Investments (CLOV -1.51%) were soaring 12% as of 11:32 a.m. EDT on Tuesday. The gain came after the company filed an amendment to a preliminary prospectus to issue additional Class B shares, which have more limited voting rights than Class A shares. This amendment acknowledged that the stock's recent momentum could be the result of a short squeeze.  

So what

Clover Health didn't just call attention in its prospectus amendment to "widespread speculation that our current trading price is the result of a short squeeze." The company also said that its share price "may rapidly decline." It even cautioned against investing in its Class B shares "unless you are prepared to incur the risk of losing all or a substantial portion of your investment."

Yellow triangular warning sign with a black outline and an exclamation point in the center.

Image source: Getty Images.

So why did the stock jump today with such a tough warning from Clover Health? Maybe because many online investors simply don't care about the risk. Clover Health's acknowledgement of the short squeeze seems to be making some more adamant about piling into the stock and riding the momentum as long as possible. 

Now what

Clover Health certainly has some solid opportunities for growth, including its direct contracting efforts with original Medicare. However, it's important to note that the company was exactly right with its cautionary language in the prospectus amendment.

Short squeezes don't last forever. When they end -- and they always end -- the stocks that initially benefited decline even more quickly than they went up.

We've already seen this happen with Clover Health stock. It more than tripled in recent weeks before giving up much of its gains. Any momentum that isn't accompanied by underlying business improvement will evaporate sooner or later.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Clover Health Investments, Corp. Stock Quote
Clover Health Investments, Corp.
CLOV
$3.25 (-1.51%) $0.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.